Scholars Central

Research articlePublished 30 Mar 2014

Established Osteoporosis and Gaps in the Management: Review from a Teaching hospital

Authors: Mir Sadat‑Ali, Al-Omran AS, Al-Bakr WI, Md Quamar Azam, Tantawy AM, Al‑Othman AA

Annals of Medical and Health Sciences Research

Volume 4 · Issue 2 · Pages 198–201

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Background: International osteoporosis foundation described severe or established osteoporosis as an osteoporotic individual with a fragility fracture. Orthopaedic surgeons frequently manage fractures, but we believe that large gaps are prevalent in the medical management of osteoporosis after fractures are fixed. Aim: The aim of this analysis is to assess the investigations and gaps in the management of osteoporosis in patients admitted with a fragility fracture of femur at King Fahd Hospital of the University, AlKhobar, Saudi Arabia. Materials and Methods: A retrospective analysis of all admission and discharge; medical and pharmacy records database of patients over ≥ 50 years with fragility fracture between January 2001 and December 2011. The outcome measures assessed were investigations such as serum calcium, phosphorous, alkaline phosphatase, parathormone, 25 hydroxy vitamin D (25OHD) levels and a dual energy X‑ray absorptiometry (DEXA). Secondly once the fracture was fixed what medications were prescribed, calcium and vitamin D, antiresorptives and anabolic agents. Results: There were 207 patients admitted during the study period with an average age of 69.2 (12.1) years and 118 were females. In 169 (81.6%) patients, the fracture site was proximal femur. Vitamin D (25OHD) was requested in 31/207 (14.9%). DEXA scan was ordered in 49/207 (24.1%). A total of 78/207 (37.6%) patients received calcium and vitamin D3 and 94/207 (45.4%) either got calcium or vitamin D3. Bisphosphonates was used in 35, miacalcic nasal spray in 25 and anabolic agent teriparatide was prescribed in 21 patients. Post‑fixation 126/207 (60.8%) patients did not receive any anti‑osteoporotic medication. In untreated group, there were 87 males and 39 females. Conclusions: The study found that in patients, who sustained a fragility fracture, confirmation of osteoporosis by DEXA was very low and ideal treatment for severe osteoporosis was given out to few patients. More efforts are needed to fill this large gap in the correct management of osteoporosis related fractures by orthopaedic surgeons.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Annals of Medical and Health Sciences Research.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalAnnals of Medical and Health Sciences Research
  • SubjectGeneral & Internal Medicine
  • BylineArticles whose byline prints “Mir Sadat‑Ali”
  • BylineArticles whose byline prints “Al-Omran AS”
  • BylineArticles whose byline prints “Al-Bakr WI”
  • BylineArticles whose byline prints “Md Quamar Azam”
  • BylineArticles whose byline prints “Tantawy AM”
  • BylineArticles whose byline prints “Al‑Othman AA”